Halozyme Therapeutics News, Halozyme Therapeutics Quote, HALO Quote

Halozyme Therapeutics (NQ:HALO) Delayed: 110.19 -0.57 (0.51%)

Prev. Close

$110.76

Today 6M 1Y 5Y

Open

$109.91

52 Wk High

$18.39

52 Wk Low

$6.96

Day High

$111.15

Day Low

$109.00

P/E

N/A

EPS

$-0.58

Volume

1,010,602

Friends, Peers and Foes (?): ORKA, RBND, VRTX, MRUS, ABBV (more...)

ALERTS | RSS

Sep 3, 2026 06:58 AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Aug 21, 2026 04:55 PM Form 3 HALOZYME THERAPEUTICS, For: Aug 14 Filed by: Appelhans Dannielle
Aug 19, 2026 08:01 PM Form 4 HALOZYME THERAPEUTICS, For: Aug 17 Filed by: Torley Helen
Aug 18, 2026 04:04 PM Form 8-K HALOZYME THERAPEUTICS, For: Aug 14
Aug 18, 2026 04:01 PM Halozyme adds biotech executive Appelhans to its board
Aug 18, 2026 04:01 PM Halozyme Appoints Dannielle Appelhans to its Board of Directors
Aug 18, 2026 06:38 AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Aug 17, 2026 05:16 PM Form 144 HALOZYME THERAPEUTICS, Filed by: Torley Helen
Aug 11, 2026 05:58 PM Form 144 HALOZYME THERAPEUTICS, Filed by: Caudill Cortney
Aug 11, 2026 05:44 PM Form 4 HALOZYME THERAPEUTICS, For: Aug 10 Filed by: Connaughton Bernadette

Entities mentioned with HALO

View All Entities